{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:57:09Z","timestamp":1790751429906,"version":"4.1.0"},"reference-count":123,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Immunogenic cell death (ICD) and tertiary lymphoid structures (TLSs) are biologically distinct yet interconnected components of antitumor immunity. ICD promotes danger-associated immune activation, whereas TLSs organize local adaptive immune responses. However, how these processes jointly affect immune heterogeneity, prognosis, and therapeutic responsiveness in lung adenocarcinoma (LUAD) remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>To define the coordinated roles of TLS- and ICD-related programs in LUAD, we used a multi-cohort and multi-layer analytical framework. This framework included transcriptomic analysis, Mendelian randomization, consensus machine-learning prognostic modeling, immune landscape characterization, single-cell RNA sequencing, multiplex immunohistochemistry, immunotherapy response assessment, exploratory drug screening, structural analyses, and multilayer network topology analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>TLS- and ICD-associated genes were transcriptionally dysregulated in LUAD. By integrating 13 machine-learning algorithms, we developed 801 candidate prognostic models and identified optimal TLS- and ICD-related models that stratified patients effectively into high- and low-risk groups. These models showed strong performance in TCGA and remained robust across six external cohorts. Low-risk tumors had higher TLS+ICD scores than high-risk tumors. Immune landscape analysis indicated that low-risk tumors had elevated immune scores, enhanced antigen presentation, cytotoxic T\/NK-cell signatures, checkpoint activation, and lower Tumor Immune Dysfunction and Exclusion (TIDE) scores, suggesting a more immunotherapy-responsive microenvironment. Consistently, higher TLS+ICD scores correlated with improved survival and greater immunotherapy responsiveness in independent cohorts. Mendelian randomization and survival analyses prioritized CD40, CD5, and GFI1 as candidate TLS\u2013ICD immune-regulatory genes, with single-cell and mIHC analyses defining their major cellular origins, spatial protein phenotypes, and prognostic relevance. Drug prediction, molecular docking, and molecular dynamics simulations identified CAY10576, SCH772984, and SZ4TA2 as potential therapeutic agents for high-risk LUAD. Multilayer gene regulatory network reconstruction and GLMY homology analysis revealed progressive disruption of higher-order immune-regulatory organization from normal to tumor tissues and between low TLS-risk\/low ICD-risk (LL-risk) and high TLS-risk\/high ICD-risk (HH-risk) states.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>TLS- and ICD-related programs jointly delineate clinically significant immune states in LUAD through convergent transcriptomic, genetic, single-cell, spatial, pharmacological, and systems-level evidence, and are associated with immune microenvironment remodeling, immunotherapy responsiveness, prognosis, and therapeutic vulnerability. These findings establish a biomarker-guided, machine learning-supported framework for LUAD risk stratification and may inform more precise immunotherapy-oriented therapeutic strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1917959","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:06:59Z","timestamp":1790748419000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Immunogenic cell death and tertiary lymphoid structures jointly define dysregulated antitumor immune states and therapeutic vulnerability in lung adenocarcinoma"],"prefix":"10.3389","volume":"17","author":[{"given":"Yuntian","family":"Lu","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, Affiliated Hospital of Nantong University, Medical School of Nantong University","place":["Nantong, China"]},{"name":"Department of Immunology, School of Medicine, Nantong University","place":["Nantong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Affiliated Hospital of Nantong University, Medical School of Nantong University","place":["Nantong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihan","family":"Meng","sequence":"additional","affiliation":[{"name":"Institute of Statistics and Big Data, Renmin University of China","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinhua","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Affiliated Hospital of Nantong University, Medical School of Nantong University","place":["Nantong, China"]},{"name":"Department of Immunology, School of Medicine, Nantong University","place":["Nantong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaoyi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Affiliated Hospital of Nantong University, Medical School of Nantong University","place":["Nantong, China"]},{"name":"Department of Immunology, School of Medicine, Nantong University","place":["Nantong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaorong","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Affiliated Hospital of Nantong University, Medical School of Nantong University","place":["Nantong, China"]},{"name":"Department of Immunology, School of Medicine, Nantong University","place":["Nantong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Affiliated Hospital of Nantong University, Medical School of Nantong University","place":["Nantong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengmeng","family":"Sang","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Affiliated Hospital of Nantong University, Medical School of Nantong University","place":["Nantong, China"]},{"name":"Department of Immunology, School of Medicine, Nantong University","place":["Nantong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-1281542\/v1","article-title":"Modeling diverse genetic subtypes of lung adenocarcinoma with a next-generation alveolar type 2 organoid platform","volume":"36","author":"Naranjo","year":"2022","journal-title":"Genes Dev"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(21)00312-3","article-title":"Lung cancer","volume":"398","author":"Thai","year":"2021","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01740-y","article-title":"Lung cancer immunotherapy: progress, pitfalls, and promises","volume":"22","author":"Lahiri","year":"2023","journal-title":"Mol Cancer"},{"key":"B4","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.cell.2020.05.043","article-title":"Integrative proteomic characterization of human lung adenocarcinoma","volume":"182","author":"Xu","year":"2020","journal-title":"Cell"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1126\/science.abf9419","article-title":"Tertiary lymphoid structures in cancer","volume":"375","author":"Schumacher","year":"2022","journal-title":"Science"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-019-0144-6","article-title":"Tertiary lymphoid structures in the era of cancer immunotherapy","volume":"19","author":"Sautes-Fridman","year":"2019","journal-title":"Nat Rev Cancer"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1080\/2162402x.2020.1724763","article-title":"Helper T cell-dominant tertiary lymphoid structures are associated with disease relapse of advanced colorectal cancer","volume":"9","author":"Yamaguchi","year":"2020","journal-title":"Oncoimmunology"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12405","article-title":"Tertiary lymphoid structures, drivers of the anti-tumor responses in human cancers","volume":"271","author":"Dieu-Nosjean","year":"2016","journal-title":"Immunol Rev"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1063711","article-title":"Tertiary lymphoid structures are critical for cancer prognosis and therapeutic response","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2023.10.022","article-title":"Tertiary lymphoid structure-associated B cells enhance CXCL13(+)CD103(+)CD8(+) tissue-resident memory T-cell response to programmed cell death protein 1 blockade in cancer immunotherapy","volume":"166","author":"Hu","year":"2024","journal-title":"Gastroenterology"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.cir-20-0432","article-title":"Insights into tumor-associated tertiary lymphoid structures: novel targets for antitumor immunity and cancer immunotherapy","volume":"8","author":"Rodriguez","year":"2020","journal-title":"Cancer Immunol Res"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-020-0457-0","article-title":"Tertiary lymphoid structures in cancer - considerations for patient prognosis","volume":"17","author":"Munoz-Erazo","year":"2020","journal-title":"Cell Mol Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-023-00623-w","article-title":"Roles of RIPK1 as a stress sentinel coordinating cell survival and immunogenic cell death","volume":"24","author":"Clucas","year":"2023","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3380","article-title":"Immunogenic cell death and DAMPs in cancer therapy","volume":"12","author":"Krysko","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202201734","article-title":"Immunogenic cell death activates the tumor immune microenvironment to boost the immunotherapy efficiency","volume":"9","author":"Li","year":"2022","journal-title":"Adv Sci (Weinh)"},{"key":"B16","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1186\/s12951-023-02067-y","article-title":"Autophagy-amplifying nanoparticles evoke immunogenic cell death combined with anti-PD-1\/PD-L1 for residual tumors immunotherapy after RFA","volume":"21","author":"Zhang","year":"2023","journal-title":"J Nanobiotechnol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2019-000337","article-title":"Consensus guidelines for the definition, detection and interpretation of immunogenic cell death","volume":"8","author":"Galluzzi","year":"2020","journal-title":"J Immunother Cancer"},{"key":"B18","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/nm1523","article-title":"Calreticulin exposure dictates the immunogenicity of cancer cell death","volume":"13","author":"Obeid","year":"2007","journal-title":"Nat Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/nm1622","article-title":"Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy","volume":"13","author":"Apetoh","year":"2007","journal-title":"Nat Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1794130","article-title":"Multidimensional tumor heterogeneity and its role in therapeutic resistance","volume":"17","author":"Mubin","year":"2026","journal-title":"Front Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1080\/2162402x.2015.1069938","article-title":"Immunological metagene signatures derived from immunogenic cancer cell death associate with improved survival of patients with lung, breast or ovarian Malignancies: a large-scale meta-analysis","volume":"5","author":"Garg","year":"2016","journal-title":"Oncoimmunology"},{"key":"B22","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s13167-023-00327-3","article-title":"Multi-omics identification of an immunogenic cell death-related signature for clear cell renal cell carcinoma in the context of 3P medicine and based on a 101-combination machine learning computational framework","volume":"14","author":"Liu","year":"2023","journal-title":"EPMA J"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.781466","article-title":"An immunogenic cell death-related classification predicts prognosis and response to immunotherapy in head and neck squamous cell carcinoma","volume":"12","author":"Wang","year":"2021","journal-title":"Front Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1049884","article-title":"Tertiary lymphoid structure patterns aid in identification of tumor microenvironment infiltration and selection of therapeutic agents in bladder cancer","volume":"13","author":"An","year":"2022","journal-title":"Front Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1914-8","article-title":"Tertiary lymphoid structures improve immunotherapy and survival in melanoma","volume":"577","author":"Cabrita","year":"2020","journal-title":"Nature"},{"key":"B26","doi-asserted-by":"publisher","first-page":"186ra66","DOI":"10.1126\/scitranslmed.3005723","article-title":"Ectopic activation of germline and placental genes identifies aggressive metastasis-prone lung cancers","volume":"5","author":"Rousseaux","year":"2013","journal-title":"Sci Transl Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-11-1403","article-title":"Identification of genes upregulated in ALK-positive and EGFR\/KRAS\/ALK-negative lung adenocarcinomas","volume":"72","author":"Okayama","year":"2012","journal-title":"Cancer Res"},{"key":"B28","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1158\/1078-0432.ccr-12-1139","article-title":"Biomarker discovery in non-small cell lung cancer: integrating gene expression profiling, meta-analysis, and tissue microarray validation","volume":"19","author":"Botling","year":"2013","journal-title":"Clin Cancer Res"},{"key":"B29","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1097\/jto.0000000000000042","article-title":"Validation of a histology-independent prognostic gene signature for early-stage, non-small-cell lung cancer including stage IA patients","volume":"9","author":"Der","year":"2014","journal-title":"J Thorac Oncol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/nm.1790","article-title":"Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study","volume":"14","author":"Shedden","year":"2008","journal-title":"Nat Med"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2015.375","article-title":"Differential association of STK11 and TP53 with KRAS mutation-associated gene expression, proliferation and immune surveillance in lung adenocarcinoma","volume":"35","author":"Schabath","year":"2016","journal-title":"Oncogene"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1260419","DOI":"10.1126\/science.1260419","article-title":"Tissue-based map of the human proteome","volume":"347","author":"Uhlen","year":"2015","journal-title":"Science"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2014-15-2-r29","article-title":"voom: precision weights unlock linear model analysis tools for RNA-seq read counts","volume":"15","author":"Law","year":"2014","journal-title":"Genome Biol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"key":"B35","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4757-3294-8","volume-title":"Modeling Survival Data: Extending the Cox Model","author":"Therneau","year":"2000"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.4149\/bll_2019_087","article-title":"Overview of artificial neural network models in the biomedical domain","volume":"120","author":"Renganathan","year":"2019","journal-title":"Bratisl Lek Listy"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1201\/9781003493679-19","article-title":"Random survival forests","volume":"2","author":"Ishwaran","year":"2008","journal-title":"Ann Appl Stat"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1111\/j.2517-6161.1996.tb02080.x","article-title":"Regression shrinkage and selection via the lasso","volume":"58","author":"Tibshirani","year":"1996","journal-title":"J R Stat Soc Ser B"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1111\/j.1467-9868.2005.00503.x","article-title":"Regularization and variable selection via the elastic net","volume":"67","author":"Zou","year":"2005","journal-title":"J R Stat Soc Ser B"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1198\/016214505000000628","article-title":"Prediction by supervised principal components","volume":"101","author":"Bair","year":"2006","journal-title":"J Am Stat Assoc"},{"key":"B41","first-page":"785","article-title":"XGBoost: a scalable tree boosting system","author":"Chen","year":"2016"},{"key":"B42","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life-tables","volume":"34","author":"Cox","year":"1972","journal-title":"J R Stat Soc Ser B"},{"key":"B43","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1093\/bioinformatics\/btu660","article-title":"Deviance residuals-based sparse PLS and sparse kernel PLS regression for censored data","volume":"31","author":"Bastien","year":"2015","journal-title":"Bioinformatics"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1214\/aos\/1013203451","article-title":"Greedy function approximation: a gradient boosting machine","volume":"29","author":"Friedman","year":"2001","journal-title":"Ann Stat"},{"key":"B45","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1080\/00401706.2000.10485983","article-title":"Ridge regression: biased estimation for nonorthogonal problems","volume":"12","author":"Hoerl","year":"1970","journal-title":"Technometrics"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.artmed.2011.06.006","article-title":"Support vector methods for survival analysis: a comparison between ranking and regression approaches","volume":"53","author":"Van Belle","year":"2011","journal-title":"Artif Intell Med"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1162\/089976600300015565","article-title":"New support vector algorithms","volume":"12","author":"Scholkopf","year":"2000","journal-title":"Neural Comput"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.5555\/3294996.3295074","article-title":"LightGBM: a highly efficient gradient boosting decision tree","volume":"30","author":"Ke","year":"2017","journal-title":"Adv Neural Inf Process Syst"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1038\/nbt1206-1565","article-title":"What is a support vector machine","volume":"24","author":"Noble","year":"2006","journal-title":"Nat Biotechnol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1504\/ijcistudies.2021.10036522","article-title":"Feature selection on educational data using Boruta algorithm","volume":"10","author":"Anand","year":"2021","journal-title":"Int J Comput Intell Stud"},{"key":"B51","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1023\/a:1010933404324","article-title":"Random forests","volume":"45","author":"Breiman","year":"2001","journal-title":"Mach Learn"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-7493-1_12","article-title":"Profiling tumor infiltrating immune cells with CIBERSORT","volume":"1711","author":"Chen","year":"2018","journal-title":"Methods Mol Biol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.687975","article-title":"IOBR: multi-omics immuno-oncology biological research to decode tumor microenvironment and signatures","volume":"12","author":"Zeng","year":"2021","journal-title":"Front Immunol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"Hanzelmann","year":"2013","journal-title":"BMC Bioinf"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1111\/cas.14621","article-title":"A novel scoring method based on RNA-Seq immunograms describing individual cancer-immunity interactions","volume":"111","author":"Kobayashi","year":"2020","journal-title":"Cancer Sci"},{"key":"B56","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.ccell.2021.04.014","article-title":"Conserved pan-cancer microenvironment subtypes predict response to immunotherapy","volume":"39","author":"Bagaev","year":"2021","journal-title":"Cancer Cell"},{"key":"B57","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.immuni.2019.08.004","article-title":"The immune landscape of cancer","volume":"48","author":"Thorsson","year":"2018","journal-title":"Immunity"},{"key":"B58","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1186\/s12967-024-05590-0","article-title":"Machine learning-based identification of biomarkers and drugs in immunologically cold and hot pancreatic adenocarcinomas","volume":"22","author":"Ge","year":"2024","journal-title":"J Transl Med"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-18-0689","article-title":"TIP: a web server for resolving tumor immunophenotype profiling","volume":"78","author":"Xu","year":"2018","journal-title":"Cancer Res"},{"key":"B60","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1038\/s41467-020-16164-1","article-title":"Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma","volume":"11","author":"Kim","year":"2020","journal-title":"Nat Commun"},{"key":"B61","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","article-title":"Integrated analysis of multimodal single-cell data","volume":"184","author":"Hao","year":"2021","journal-title":"Cell"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1038\/s41592-019-0619-0","article-title":"Fast, sensitive and accurate integration of single-cell data with Harmony","volume":"16","author":"Korsunsky","year":"2019","journal-title":"Nat Methods"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","article-title":"Inference and analysis of cell-cell communication using CellChat","volume":"12","author":"Jin","year":"2021","journal-title":"Nat Commun"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-022-04555-4","article-title":"Novel immunogenic cell death-related risk signature to predict prognosis and immune microenvironment in lung adenocarcinoma","volume":"149","author":"Li","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3892","article-title":"Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes","volume":"49","author":"McKay","year":"2017","journal-title":"Nat Genet"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-05473-8","article-title":"FinnGen provides genetic insights from a well-phenotyped isolated population","volume":"613","author":"Kurki","year":"2023","journal-title":"Nature"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyr036","article-title":"Avoiding bias from weak instruments in Mendelian randomization studies","volume":"40","author":"Burgess","year":"2011","journal-title":"Int J Epidemiol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btw373","article-title":"PhenoScanner: a database of human genotype-phenotype associations","volume":"32","author":"Staley","year":"2016","journal-title":"Bioinformatics"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression","volume":"44","author":"Bowden","year":"2015","journal-title":"Int J Epidemiol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1002\/sim.6632","article-title":"Misunderstandings about Q and Cochran's Q test in meta-analysis","volume":"35","author":"Hoaglin","year":"2016","journal-title":"Stat Med"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0045-3","article-title":"Global characterization of T cells in non-small-cell lung cancer by single-cell sequencing","volume":"24","author":"Guo","year":"2018","journal-title":"Nat Med"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03752-4","article-title":"Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers","volume":"596","author":"Caushi","year":"2021","journal-title":"Nature"},{"key":"B73","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.stem.2020.07.022","article-title":"Organoids model transcriptional hallmarks of oncogenic KRAS activation in lung epithelial progenitor cells","volume":"27","author":"Dost","year":"2020","journal-title":"Cell Stem Cell"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-002312","article-title":"Multiomics analysis reveals a distinct response mechanism in multiple primary lung adenocarcinoma after neoadjuvant immunotherapy","volume":"9","author":"Zhang","year":"2021","journal-title":"J Immunother Cancer"},{"key":"B75","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.immuni.2022.02.005","article-title":"Mechanistic convergence of the TIGIT and PD-1 inhibitory pathways necessitates co-blockade to optimize anti-tumor CD8+ T cell responses","volume":"55","author":"Banta","year":"2022","journal-title":"Immunity"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/j.immuni.2019.03.009","article-title":"Single-cell transcriptomics of human and mouse lung cancers reveals conserved myeloid populations across individuals and species","volume":"50","author":"Zilionis","year":"2019","journal-title":"Immunity"},{"key":"B77","doi-asserted-by":"publisher","first-page":"3561","DOI":"10.1038\/s41467-024-47900-6","article-title":"HBO1 catalyzes lysine lactylation and mediates histone H3K9la to regulate gene transcription","volume":"15","author":"Niu","year":"2024","journal-title":"Nat Commun"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbab260","article-title":"oncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data","volume":"22","author":"Maeser","year":"2021","journal-title":"Brief Bioinform"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gky092","article-title":"UniProt: the universal protein knowledgebase","volume":"45","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkr1132","article-title":"PubChem's BioAssay database","volume":"40","author":"Wang","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1002\/jcc.23905","article-title":"DOCK 6: impact of new features and current docking performance","volume":"36","author":"Allen","year":"2015","journal-title":"J Comput Chem"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1002\/jcc.20291","article-title":"GROMACS: fast, flexible, and free","volume":"26","author":"Van Der Spoel","year":"2005","journal-title":"J Comput Chem"},{"key":"B83","volume-title":"Gaussview, Version 6","author":"Dennington","year":"2016"},{"key":"B84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.physrep.2023.07.006","article-title":"The genomic physics of tumor-microenvironment crosstalk","volume":"1029","author":"Sang","year":"2023","journal-title":"Phys Rep"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1534\/genetics.108.093690","article-title":"A computational approach to the functional clustering of periodic gene-expression profiles","volume":"180","author":"Kim","year":"2008","journal-title":"Genetics"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.2202\/1544-6115.1136","article-title":"Structured antedependence models for functional mapping of multiple longitudinal traits","volume":"4","author":"Zhao","year":"2005","journal-title":"Stat Appl Genet Mol Biol"},{"key":"B87","unstructured":"Homologies of path complexes and digraphs\n          \n          \n            \n              Grigor\u2019yan\n              A\n            \n            \n              Lin\n              Y\n            \n            \n              Muranov\n              Y\n            \n            \n              Yau\n              S-T\n            \n          \n          10.48550\/arXiv.1207.2834\n          arXiv [preprint]\n          \n          2012"},{"key":"B88","unstructured":"Stability of persistent path diagrams\n          \n          \n            \n              Zhang\n              S\n            \n          \n          10.48550\/arXiv.2406.11998\n          arXiv [preprint]\n          \n          2024"},{"key":"B89","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.ccell.2019.01.003","article-title":"Distinct immune cell populations define response to anti-PD-1 monotherapy and anti-PD-1\/anti-CTLA-4 combined therapy","volume":"35","author":"Gide","year":"2019","journal-title":"Cancer Cell"},{"key":"B90","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1038\/s41467-017-01460-0","article-title":"Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma","volume":"8","author":"Lauss","year":"2017","journal-title":"Nat Commun"},{"key":"B91","doi-asserted-by":"publisher","first-page":"4278","DOI":"10.1038\/s41467-019-12159-9","article-title":"DNA methylation loss promotes immune evasion of tumours with high mutation and copy number load","volume":"10","author":"Jung","year":"2019","journal-title":"Nat Commun"},{"key":"B92","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nri.2016.107","article-title":"Immunogenic cell death in cancer and infectious disease","volume":"17","author":"Galluzzi","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"B93","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/s41419-020-03221-2","article-title":"Detection of immunogenic cell death and its relevance for cancer therapy","volume":"11","author":"Fucikova","year":"2020","journal-title":"Cell Death Dis"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-024-00728-0","article-title":"Tertiary lymphoid structures in anticancer immunity","volume":"24","author":"Teillaud","year":"2024","journal-title":"Nat Rev Cancer"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2022-328697","article-title":"Mature tertiary lymphoid structures are key niches of tumour-specific immune responses in pancreatic ductal adenocarcinomas","volume":"72","author":"Kinker","year":"2023","journal-title":"Gut"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-024-01998-y","article-title":"Multi-omic profiling highlights factors associated with resistance to immuno-chemotherapy in non-small-cell lung cancer","volume":"57","author":"Yan","year":"2025","journal-title":"Nat Genet"},{"key":"B97","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/s41392-024-01947-5","article-title":"Tertiary lymphoid structures in diseases: immune mechanisms and therapeutic advances","volume":"9","author":"Zhao","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.5731","article-title":"Clinical implications and molecular features of tertiary lymphoid structures in stage I lung adenocarcinoma","volume":"12","author":"Xu","year":"2023","journal-title":"Cancer Med"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.18632\/aging.205077","article-title":"The integrated single-cell analysis developed an immunogenic cell death signature to predict lung adenocarcinoma prognosis and immunotherapy","volume":"15","author":"Zhang","year":"2023","journal-title":"Aging (Albany NY)"},{"key":"B100","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1146\/annurev-med-062518-045435","article-title":"CD40 agonist antibodies in cancer immunotherapy","volume":"71","author":"Vonderheide","year":"2020","journal-title":"Annu Rev Med"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1080\/14737140.2017.1270208","article-title":"Cancer immunotherapy: activating innate and adaptive immunity through CD40 agonists","volume":"17","author":"Beatty","year":"2017","journal-title":"Expert Rev Anticancer Ther"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1038\/cmi.2016.42","article-title":"CD5 expression promotes IL-10 production through activation of the MAPK\/Erk pathway and upregulation of TRPC1 channels in B lymphocytes","volume":"15","author":"Garaud","year":"2018","journal-title":"Cell Mol Immunol"},{"key":"B103","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1084\/jem.201014992084c","article-title":"Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20+ CD27+ CD43+ CD70","volume":"208","author":"Griffin","year":"2011","journal-title":"J Exp Med"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1038\/nature02994","article-title":"Gfi-1 restricts proliferation and preserves functional integrity of haematopoietic stem cells","volume":"431","author":"Hock","year":"2004","journal-title":"Nature"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-019-0222-4","article-title":"Tumour-associated neutrophils in patients with cancer","volume":"16","author":"Shaul","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-05672-3","article-title":"Single-cell spatial landscapes of the lung tumour immune microenvironment","volume":"614","author":"Sorin","year":"2023","journal-title":"Nature"},{"key":"B107","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1038\/s41467-025-56546-x","article-title":"Spatially mapping the tumour immune microenvironments of non-small cell lung cancer","volume":"16","author":"Desharnais","year":"2025","journal-title":"Nat Commun"},{"key":"B108","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/j.ccell.2025.04.003","article-title":"Spatial and multiomics analysis of human and mouse lung adenocarcinoma precursors reveals TIM-3 as a putative target for precancer interception","volume":"43","author":"Zhu","year":"2025","journal-title":"Cancer Cell"},{"key":"B109","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.cell.2024.10.042","article-title":"Fibroblastic reticular cells generate protective intratumoral T cell environments in lung cancer","volume":"188","author":"Onder","year":"2025","journal-title":"Cell"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.cd-23-1380","article-title":"Spatial architecture of myeloid and T cells orchestrates immune evasion and clinical outcome in lung cancer","volume":"14","author":"Enfield","year":"2024","journal-title":"Cancer Discov"},{"key":"B111","doi-asserted-by":"publisher","first-page":"9701","DOI":"10.1038\/s41467-025-65783-z","article-title":"AI-powered spatial cell phenomics enhances risk stratification in non-small cell lung cancer","volume":"16","author":"Schallenberg","year":"2025","journal-title":"Nat Commun"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2006.09.018","article-title":"5-(1H-Benzimidazol-1-yl)-3-alkoxy-2-thiophenecarbonitriles as potent, selective, inhibitors of IKK-epsilon kinase","volume":"16","author":"Bamborough","year":"2006","journal-title":"Bioorg Med Chem Lett"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-16-0069","article-title":"IKBKE is a substrate of EGFR and a therapeutic target in non-small cell lung cancer with activating mutations of EGFR","volume":"76","author":"Challa","year":"2016","journal-title":"Cancer Res"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2020.07.004","article-title":"I\u03baB kinase-\u03f5-mediated phosphorylation triggers IRF-1 degradation in breast cancer cells","volume":"22","author":"Remoli","year":"2020","journal-title":"Neoplasia"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.cd-13-0070","article-title":"Discovery of a novel ERK inhibitor with activity in models of acquired resistance to BRAF and MEK inhibitors","volume":"3","author":"Morris","year":"2013","journal-title":"Cancer Discov"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio.1629","article-title":"A unique inhibitor binding site in ERK1\/2 is associated with slow binding kinetics","volume":"10","author":"Chaikuad","year":"2014","journal-title":"Nat Chem Biol"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-13-194","article-title":"Antitumor activity of the ERK inhibitor SCH772984 [corrected] against BRAF mutant, NRAS mutant and wild-type melanoma","volume":"13","author":"Wong","year":"2014","journal-title":"Mol Cancer"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2019.10.009","article-title":"LKB1 deficiency renders NSCLC cells sensitive to ERK inhibitors","volume":"15","author":"Caiola","year":"2020","journal-title":"J Thorac Oncol"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1021\/ja802683u","article-title":"Bcl-XL-templated assembly of its own protein-protein interaction modulator from fragments decorated with thio acids and sulfonyl azides","volume":"130","author":"Hu","year":"2008","journal-title":"J Am Chem Soc"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-12-2272","article-title":"Novel small-molecule inhibitors of Bcl-XL to treat lung cancer","volume":"73","author":"Park","year":"2013","journal-title":"Cancer Res"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2012.11.007","article-title":"Synthetic lethal interaction of combined BCL-XL and MEK inhibition promotes tumor regressions in KRAS mutant cancer models","volume":"23","author":"Corcoran","year":"2013","journal-title":"Cancer Cell"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (TIME) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat Med"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1126\/science.aad0501","article-title":"Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq","volume":"352","author":"Tirosh","year":"2016","journal-title":"Science"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1917959\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:07:01Z","timestamp":1790748421000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1917959\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,30]]},"references-count":123,"alternative-id":["10.3389\/fimmu.2026.1917959"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1917959","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,30]]},"article-number":"1917959"}}